secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001493152-23-025769
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical shareholders approve 2023 equity plan and three charter amendments
--------------------------------------------------------------------------------

- Stockholders approved 2023 Equity Incentive Plan with 5.5M new shares plus rollover from prior plan; effective through July 25, 2033.
- Approved charter amendments: supermajority director vote to fix board >7, officer exculpation per DGCL, and exclusive forum change.
- Re-elected six directors: Bakewell, Beeson, Browne, McNamara, Mitchell-Keller, Vizirgianakis with >87M votes each.
- Ratified Plante & Moran as auditor for FY2023 (95.5M for, 11.6K against). Advisory say-on-pay passed with 87.2M votes for.
- Amendments filed with Delaware Secretary of State on July 26, 2023; equity plan replaces 2018 plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223025769/0001493152-23-025769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223025769/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer